clostridium difficile presented by nate smith, md, mph carole yeung, rn cic

34
Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

Upload: brandy-layson

Post on 15-Jan-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

Clostridium difficile

Presented byNate Smith, MD, MPHCarole Yeung, RN CIC

Page 2: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

2

Outline

• Epidemiology

• Treatment

• Prevention

Page 3: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

3

What is Clostridium difficile?

• Anaerobic spore-forming bacillus• Present in the soil and environment• Produces two toxins – Toxins A and B• Common cause of antibiotic associated diarrhea

(AAD). 15 – 25 % all episodes of AAD• Health care settings are major reservoirs• 20 – 40% hospital patients colonized• 4 – 20% LTCF residents colonized

Page 4: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

4

What are C. difficile-associated diseases (CDAD)

• Pseudomembranous colitis (PMC)

• Toxic megacolon

• Perforations of the colon

• Sepsis

• Death (rarely) but increasing!

Page 5: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

5

CDAD-related deaths - Arkansas

0

10

20

30

40

50

60

DE

AT

HS

1999 2000 2001 2002 2003 2004 2005*

*2005 data incomplete

Page 6: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

6

Page 7: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

7

Symptoms of CDAD

• Watery diarrhea• Fever• Loss of appetite• Abdominal pain• Nausea and vomiting• Severe cases: increase WBC and/or creatinine • Can occur up to 8 weeks after antimicrobial

therapy

Page 8: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

8

Which patients are at increased risk for CDAD?

• Antibiotic exposure – clindamycin, penicillins, cephalosporins, floroquinolones

• Gastrointestinal surgery

• Length of stay in healthcare settings

• A serious underlying illness

• Immunocompromising conditions

• Advanced age

Page 9: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

9

C. difficile colonization

• Patient exhibits no clinical symptoms

• Patient tests positive for C. difficile organism and/or its toxin

• More common than CDAD

Page 10: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

10

C. difficile disease (CDAD)

• Patient exhibits clinical symptoms

• Patient tests positive for C. difficile organism and/or its toxin

Page 11: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

11

Laboratory Tests for CDAD

• Stool culture

• Antigen detection

• Toxin testing

Page 12: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

12

C. difficile Transmission

• C. difficile spores are shed in feces

• Any surface, device or material that becomes contaminated with feces may serve as a reservoir

• Transferred by hands of healthcare personnel

Page 13: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

13

Treatment

• Discontinue antibiotics if feasible

• Metronidazole orally for 10 days

• Vancomycin orally

• Relapses are common

• Repeat testing NOT recommended

• NO antiperistalic agents

Page 14: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

14

Infection Control Preventive Methods

• Use antibiotics judiciously

• Early diagnosis

• Contact precautions for patients with CDAD

• Hand hygiene

• Environmental cleaning and disinfection

Page 15: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

15

Contact Precautions

• Private room or cohort

• Gloves

• Gowns

• Dedicated patient care equipment

Page 16: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

16

Hand Hygiene

Soap and water for at least 15 seconds:

• Wet hands under running water

• Apply soap

• Good friction rub for 15 seconds

• Rinse hands

• Dry well with paper towel

Page 17: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

17

Page 18: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

18

Page 19: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

19

Page 20: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

20

Page 21: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

21

Page 22: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

22

Page 23: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

23

Page 24: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

24

Page 25: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

25

Page 26: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

26

Page 27: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

27

Page 28: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

28

Page 29: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

29

Page 30: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

30

Cleaning and Disinfection

• Clean/disinfect environmental surfaces and reusable items

• Hospital disinfectant

• 1:10 bleach

Page 31: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

31

Discontinuing Precautions

• NO diarrhea. NO precautions!

• Repeat testing NOT recommended

Page 32: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

32

Transfer of Patients

• Notify receiving facility if patient has a history of C. difficile

• Observe for recurrence

Page 33: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

33

References

• SHEA Position Paper CDAD, ICHE 1995

• SHEA Position Paper C. difficile in LTCF for the elderly, ICHE 2002

Page 34: Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC

34

QUESTIONS?